Five early-career researchers have been awarded four-year fellowships under the LUMC Junior Principal Investigator (PI) Programme 2025. Each receives €850,000 to launch an independent research line within LUMC, with a strong emphasis on translating scientific insight into clinical application.
This year’s awardees include researchers working on personalised interventions for cardiometabolic diseases, new immunotherapies targeting B cells, brain waste clearance mechanisms, host–pathogen interactions, and chronic inflammation in IBD. The diversity of topics reflects LUMC’s focus on high-impact research that cuts across traditional disciplinary boundaries.
The programme is designed to accelerate the careers of talented postdocs by offering them full research independence, a formal PI status, and access to core facilities. It also strengthens LUMC’s position as a national leader in developing future scientific leadership. Each fellow will lead a small team and is expected to compete for follow-up funding through major national and international schemes.
The 2026 call is now open, and applicants are encouraged to align their proposals with LUMC’s strategic research themes.
Meet the 2025 fellows and learn how to apply for the next round here.
A month after being cleared to sell its animal-free meat fat in the US, Nourish Ingredients has set its sights on the global market with a new commercial hub in the Netherlands....
Dutch biotech Leyden Labs has raised a €30 million equity investment from the European Innovation Council (EIC) Fund and Invest-NL to accelerate the development of its PanFlu...
Leiden, 26 September 2025. For the first time, LUMC has used a surgical robot to remove a piece of liver from a living donor and successfully transplant it into a patient. A...